Skip to main content

LGT Financial Advisors LLC

Position in ABBV — AbbVie Inc.

CIK 1965191 DALLAS, TX

Position in ABBV

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$508,816
+$179,537 QoQ
Shares Held
2,022
+33.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
4.05%
of 13F equity value
Holder Rank
#3,131
of 4,153 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Jun 30, 2023
CallValue
$67,365
CallShares
500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

LGT Financial Advisors LLC holds $591,610 across 2 Drug Manufacturers - General names. ABBV ranks #1 (86.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABBV
AbbVie Inc.
This page
2,022 $508,816

All Filings in ABBV

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $508,816 2,022
2026-03-31 $329,279 1,514
2025-12-31 $344,562 1,508
2025-09-30 $347,773 1,502
2025-06-30 $277,501 1,495
2025-03-31 $298,984 1,427
2024-12-31 $315,594 1,776
2024-09-30 $348,550 1,765
2024-06-30 $416,448 2,428
2024-03-31 $503,321 2,764
2023-12-31 $425,392 2,745
2023-09-30 $445,093 2,986
2023-06-30 $466,974 3,466
2023-06-30 $67,365 500
2023-03-31 $469,185 2,944
2022-12-31 $472,386 2,923